NANOMIX Corp (NNMX) Financial Statements (2024 and earlier)

Company Profile

Business Address 354 MERRIMACK STREET
LAWRENCE, MA 01843
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2977712137687
Cash and cash equivalents2977712137687
Receivables    015
Inventory, net of allowances, customer advances and progress billings  2413955
Inventory  2413955
Other undisclosed current assets171101390821583
Total current assets:4692023922391830
Noncurrent Assets
Operating lease, right-of-use asset   
Property, plant and equipment339 1242
Intangible assets, net (including goodwill)  1,134 515509573
Goodwill     7070
Intangible assets, net (excluding goodwill)  1,134 515439504
Deposits noncurrent assets98     
Other undisclosed noncurrent assets  (1,134)    
Total noncurrent assets:437 1517513575
TOTAL ASSETS:90620241,4399041,405
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,4671,8071,0981,670652667
Interest and dividends payable333     
Accounts payable408531458510299319
Accrued liabilities7261,2762,4591,161353347
Other undisclosed accounts payable and accrued liabilities   (1,819)   
Debt2006507004501,207 
Derivative instruments and hedges, liabilities  3954429 
Due to related parties9033,0662,101758278298
Other liabilities 12     
Other undisclosed current liabilities7443,0753,7881,7261,122112
Total current liabilities:3,3258,6007,6964,6593,6881,077
Noncurrent Liabilities
Long-term debt and lease obligation      365
Long-term debt, excluding current maturities      365
Liabilities, other than long-term debt      
Lease deposit liability   
Operating lease, liability   
Other undisclosed noncurrent liabilities3,616  9261,0993,082
Total noncurrent liabilities:3,616  9261,0993,447
Total liabilities:6,9418,6007,6965,5854,7874,524
Equity
Equity, attributable to parent, including:(21,670)(8,580)(7,672)(4,146)(3,884)(3,119)
Preferred stock  0 00 
Common stock51111111106447
Common stock, share subscribed but unissued, subscriptions receivable      
Additional paid in capital85,09219,32319,32319,15615,86315,061
Accumulated deficit(106,788)(28,014)(27,106)(23,412)(19,811)(18,226)
Other undisclosed equity, attributable to parent20 0   
Other undisclosed equity15,635     
Total equity:(6,035)(8,580)(7,672)(4,146)(3,884)(3,119)
TOTAL LIABILITIES AND EQUITY:90620241,4399041,405

Income Statement (P&L) ($ in thousands)

12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues142916322999
Revenue, net7 
Other income      
Cost of revenue
(Cost of Goods and Services Sold)
(435)  (32)(13)(94)
Gross profit:(293)916(0)165
Operating expenses(5,867)(795)(3,877)(3,311)(1,295)(1,269)
Other undisclosed operating income435  3213 
Operating loss:(5,725)(786)(3,860)(3,279)(1,266)(1,264)
Nonoperating income (expense)2,057    (402)
Debt instrument, convertible, beneficial conversion feature5,797     
Other nonoperating expense(3,740)    (402)
Interest and debt expense(3,863)(430)(343)2(1,738)(1,943)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  308509(324)1,419(125)
Loss from continuing operations before equity method investments, income taxes:(7,532)(908)(3,694)(3,601)(1,585)(3,734)
Other undisclosed income (loss) from continuing operations before income taxes(1,934)     
Loss from continuing operations before income taxes:(9,465)(908)(3,694)(3,601)(1,585)(3,734)
Income tax expense      (4)
Loss from continuing operations:(9,465)(908)(3,694)(3,601)(1,585)(3,738)
Loss before gain (loss) on sale of properties:(9,465)(908)(3,694)(3,601)(1,585)(3,738)
Net loss attributable to parent:(9,465)(908)(3,694)(3,601)(1,585)(3,738)
Preferred stock dividends and other adjustments      
Net loss available to common stockholders, basic:(9,465)(908)(3,694)(3,601)(1,585)(3,738)
Other undisclosed net loss available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(9,465)(908)(3,694)(3,601)(1,585)(3,738)

Comprehensive Income ($ in thousands)

12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(9,465)(908)(3,694)(3,601)(1,585)(3,738)
Comprehensive loss, net of tax, attributable to parent:(9,465)(908)(3,694)(3,601)(1,585)(3,738)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: